Research articlePublished 8 Jun 2023

Atypical and Anaplastic Meningiomas: Risk Factors, Classification and Management Choice

Authors: Wael K Zakaria

Insights in Neurosurgery

Volume 7 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Non benign meningiomas include atypical type (WHO grade II tumor) and anaplastic type (WHO grade III tumor). Usually, Gross Total Resection (GTR) at the time of diagnosis considered as the line of management, but subsequent prognosis and optimal management remain unclear. Methods: A retrospective study of 59 patients whom diagnosed as atypical or anaplastic meningioma in our institution from March 2006 to August 2022. Risk factors as age, sex and tumor location, extent of tumor resection were analyzed to determine their impact on tumor progression. Results: This study included 59 newly diagnosed patients with malignant meningioma (40 females and 19 males, median age 51 years, range 3 to 80 years); attending to Mansoura University Hospital (MUH), 62.7% of them were in convexity, 100.0% of cases underwent total surgical resection and postoperative radiotherapy. Recurrence occurred in 27.1% of cases mainly in anaplastic with significant P value. Demographic data as age, gender, tumor location not show significant difference in atypical and malignant type and not considered as significant risk factors. The anaplastic meningioma was significant risk factor than the atypical type. Conclusion: Patients with an anaplastic meningioma may develop a recurrent tumor than an atypical type. The anaplastic meningioma was significant risk factor for shorter overall survival and for shorter disease free survival. Radical surgical excision of the tumor or administration of adjuvant radiotherapy following initial incomplete surgical resection appears crucial for long-term treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInsights in Neurosurgery
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Wael K Zakaria”